Across clinical environments, ACI Kacin 500mg Injection targets multi-drug resistant gram-negative bacteria. This aminoglycoside antibiotic halts protein synthesis within pathogens to stop infection. Ten 2ml ampoules provide measured dosing for systemic conditions like septicemia or meningitis.
Key Features
- Broad-Spectrum Aminoglycoside: Amikacin sulfate 500mg inhibits bacterial growth across diverse strains. Stops severe infection spread in hospital environments.
- Dual Administration Route: Support for both intramuscular and intravenous injection methods. Enables flexible delivery based on patient medical status.
- Systemic Infection Control: Potent action against resistant gram-negative organisms. Clears bacterial septicemia where standard antibiotics fail.
- Thermal Stability Requirements: Under high thermal stress, chemical integrity remains intact below 30°C. Resists degradation during heat spikes in local BD clinics.
Frequently Asked Questions
What is Kacin 500mg used for?
This injection treats life-threatening infections including meningitis and bacterial septicemia. It kills sensitive gram-negative bacteria by disrupting their protein production.
Can Kacin be given intravenously?
Medical staff administer this drug via intravenous or intramuscular routes. Intravenous delivery facilitates rapid systemic distribution in acute cases.
